Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2022

View Archived Issues

LBX2 is a marker of colon adenocarcinoma

Endonuclease V is a diagnostic and prognostic marker in colon adenocarcinoma

CDK9 inhibition as promising therapeutic strategy against HCC

Chinese researchers patent sigma-1 receptor agonists

Sichuan Haisco Pharmaceutical discloses new JAK inhibitors

Immunophage Biomedical presents new CCR8 antagonists

Shanghai Institute of Materia Medica identifies new S1PR1 agonists

Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors

New approach integrates CAR-T cell immunotherapy with local activation of small-molecule prodrugs

Engineered virus-like particles for in vivo delivery of gene editing proteins

Oasmia advances its next-generation XR-18 drug delivery technology

IM-1761065, a novel biguanide with promising activity in models of glioblastoma

HS6ST2 predicts survival in PDAC

Anti-ANXA1 antibody MDX-124 shows promise in preclinical models of pancreatic cancer

Sorrento's STI-9167 neutralizes Omicron and Omicron (+R346k) variants of SARS-CoV-2

TACH-101 shows activity in gastric and colorectal cancer models

Small molecule improves AD neuropathology in mice

Juva Life advances JUVA-041 into preclinical development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...